Cargando…

Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise

Background: The majority of data regarding tissue substrate for post myocardial infarction (MI) VT has been collected during hemodynamically tolerated VT, which may be distinct from the substrate responsible for VT with hemodynamic compromise (VT-HC). This study aimed to characterize tissue at diast...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitaker, John, Neji, Radhouene, Kim, Steven, Connolly, Adam, Aubriot, Thierry, Calvo, Justo Juliá, Karim, Rashed, Roney, Caroline H., Murfin, Brendan, Richardson, Carla, Morgan, Stephen, Ismail, Tevfik F., Harrison, James, de Vos, Judith, Aalders, Maurice C. G., Williams, Steven E., Mukherjee, Rahul, O'Neill, Louisa, Chubb, Henry, Tschabrunn, Cory, Anter, Elad, Camporota, Luigi, Niederer, Steven, Roujol, Sébastien, Bishop, Martin J., Wright, Matthew, Silberbauer, John, Razavi, Reza, O'Neill, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576410/
https://www.ncbi.nlm.nih.gov/pubmed/34765656
http://dx.doi.org/10.3389/fcvm.2021.744779
_version_ 1784595870171267072
author Whitaker, John
Neji, Radhouene
Kim, Steven
Connolly, Adam
Aubriot, Thierry
Calvo, Justo Juliá
Karim, Rashed
Roney, Caroline H.
Murfin, Brendan
Richardson, Carla
Morgan, Stephen
Ismail, Tevfik F.
Harrison, James
de Vos, Judith
Aalders, Maurice C. G.
Williams, Steven E.
Mukherjee, Rahul
O'Neill, Louisa
Chubb, Henry
Tschabrunn, Cory
Anter, Elad
Camporota, Luigi
Niederer, Steven
Roujol, Sébastien
Bishop, Martin J.
Wright, Matthew
Silberbauer, John
Razavi, Reza
O'Neill, Mark
author_facet Whitaker, John
Neji, Radhouene
Kim, Steven
Connolly, Adam
Aubriot, Thierry
Calvo, Justo Juliá
Karim, Rashed
Roney, Caroline H.
Murfin, Brendan
Richardson, Carla
Morgan, Stephen
Ismail, Tevfik F.
Harrison, James
de Vos, Judith
Aalders, Maurice C. G.
Williams, Steven E.
Mukherjee, Rahul
O'Neill, Louisa
Chubb, Henry
Tschabrunn, Cory
Anter, Elad
Camporota, Luigi
Niederer, Steven
Roujol, Sébastien
Bishop, Martin J.
Wright, Matthew
Silberbauer, John
Razavi, Reza
O'Neill, Mark
author_sort Whitaker, John
collection PubMed
description Background: The majority of data regarding tissue substrate for post myocardial infarction (MI) VT has been collected during hemodynamically tolerated VT, which may be distinct from the substrate responsible for VT with hemodynamic compromise (VT-HC). This study aimed to characterize tissue at diastolic locations of VT-HC in a porcine model. Methods: Late Gadolinium Enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging was performed in eight pigs with healed antero-septal infarcts. Seven pigs underwent electrophysiology study with venous arterial-extra corporeal membrane oxygenation (VA-ECMO) support. Tissue thickness, scar and heterogeneous tissue (HT) transmurality were calculated at the location of the diastolic electrograms of mapped VT-HC. Results: Diastolic locations had median scar transmurality of 33.1% and a median HT transmurality 7.6%. Diastolic activation was found within areas of non-transmural scar in 80.1% of cases. Tissue activated during the diastolic component of VT circuits was thinner than healthy tissue (median thickness: 5.5 mm vs. 8.2 mm healthy tissue, p < 0.0001) and closer to HT (median distance diastolic tissue: 2.8 mm vs. 11.4 mm healthy tissue, p < 0.0001). Non-scarred regions with diastolic activation were closer to steep gradients in thickness than non-scarred locations with normal EGMs (diastolic locations distance = 1.19 mm vs. 9.67 mm for non-diastolic locations, p < 0.0001). Sites activated late in diastole were closest to steep gradients in tissue thickness. Conclusions: Non-transmural scar, mildly decreased tissue thickness, and steep gradients in tissue thickness represent the structural characteristics of the diastolic component of reentrant circuits in VT-HC in this porcine model and could form the basis for imaging criteria to define ablation targets in future trials.
format Online
Article
Text
id pubmed-8576410
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85764102021-11-10 Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise Whitaker, John Neji, Radhouene Kim, Steven Connolly, Adam Aubriot, Thierry Calvo, Justo Juliá Karim, Rashed Roney, Caroline H. Murfin, Brendan Richardson, Carla Morgan, Stephen Ismail, Tevfik F. Harrison, James de Vos, Judith Aalders, Maurice C. G. Williams, Steven E. Mukherjee, Rahul O'Neill, Louisa Chubb, Henry Tschabrunn, Cory Anter, Elad Camporota, Luigi Niederer, Steven Roujol, Sébastien Bishop, Martin J. Wright, Matthew Silberbauer, John Razavi, Reza O'Neill, Mark Front Cardiovasc Med Cardiovascular Medicine Background: The majority of data regarding tissue substrate for post myocardial infarction (MI) VT has been collected during hemodynamically tolerated VT, which may be distinct from the substrate responsible for VT with hemodynamic compromise (VT-HC). This study aimed to characterize tissue at diastolic locations of VT-HC in a porcine model. Methods: Late Gadolinium Enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging was performed in eight pigs with healed antero-septal infarcts. Seven pigs underwent electrophysiology study with venous arterial-extra corporeal membrane oxygenation (VA-ECMO) support. Tissue thickness, scar and heterogeneous tissue (HT) transmurality were calculated at the location of the diastolic electrograms of mapped VT-HC. Results: Diastolic locations had median scar transmurality of 33.1% and a median HT transmurality 7.6%. Diastolic activation was found within areas of non-transmural scar in 80.1% of cases. Tissue activated during the diastolic component of VT circuits was thinner than healthy tissue (median thickness: 5.5 mm vs. 8.2 mm healthy tissue, p < 0.0001) and closer to HT (median distance diastolic tissue: 2.8 mm vs. 11.4 mm healthy tissue, p < 0.0001). Non-scarred regions with diastolic activation were closer to steep gradients in thickness than non-scarred locations with normal EGMs (diastolic locations distance = 1.19 mm vs. 9.67 mm for non-diastolic locations, p < 0.0001). Sites activated late in diastole were closest to steep gradients in tissue thickness. Conclusions: Non-transmural scar, mildly decreased tissue thickness, and steep gradients in tissue thickness represent the structural characteristics of the diastolic component of reentrant circuits in VT-HC in this porcine model and could form the basis for imaging criteria to define ablation targets in future trials. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8576410/ /pubmed/34765656 http://dx.doi.org/10.3389/fcvm.2021.744779 Text en Copyright © 2021 Whitaker, Neji, Kim, Connolly, Aubriot, Calvo, Karim, Roney, Murfin, Richardson, Morgan, Ismail, Harrison, de Vos, Aalders, Williams, Mukherjee, O'Neill, Chubb, Tschabrunn, Anter, Camporota, Niederer, Roujol, Bishop, Wright, Silberbauer, Razavi and O'Neill. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Whitaker, John
Neji, Radhouene
Kim, Steven
Connolly, Adam
Aubriot, Thierry
Calvo, Justo Juliá
Karim, Rashed
Roney, Caroline H.
Murfin, Brendan
Richardson, Carla
Morgan, Stephen
Ismail, Tevfik F.
Harrison, James
de Vos, Judith
Aalders, Maurice C. G.
Williams, Steven E.
Mukherjee, Rahul
O'Neill, Louisa
Chubb, Henry
Tschabrunn, Cory
Anter, Elad
Camporota, Luigi
Niederer, Steven
Roujol, Sébastien
Bishop, Martin J.
Wright, Matthew
Silberbauer, John
Razavi, Reza
O'Neill, Mark
Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
title Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
title_full Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
title_fullStr Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
title_full_unstemmed Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
title_short Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
title_sort late gadolinium enhancement cardiovascular magnetic resonance assessment of substrate for ventricular tachycardia with hemodynamic compromise
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576410/
https://www.ncbi.nlm.nih.gov/pubmed/34765656
http://dx.doi.org/10.3389/fcvm.2021.744779
work_keys_str_mv AT whitakerjohn lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT nejiradhouene lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT kimsteven lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT connollyadam lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT aubriotthierry lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT calvojustojulia lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT karimrashed lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT roneycarolineh lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT murfinbrendan lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT richardsoncarla lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT morganstephen lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT ismailtevfikf lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT harrisonjames lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT devosjudith lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT aaldersmauricecg lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT williamsstevene lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT mukherjeerahul lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT oneilllouisa lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT chubbhenry lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT tschabrunncory lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT anterelad lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT camporotaluigi lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT niederersteven lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT roujolsebastien lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT bishopmartinj lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT wrightmatthew lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT silberbauerjohn lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT razavireza lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise
AT oneillmark lategadoliniumenhancementcardiovascularmagneticresonanceassessmentofsubstrateforventriculartachycardiawithhemodynamiccompromise